天茂集團(000627.SZ):2024年度預虧5億元–7.5億元
格隆匯1月20日丨天茂集團(000627.SZ)公佈2024年度業績預吿,2024年歸屬於上市公司股東的淨利潤虧損5億元–7.5億元,上年同期虧損6.52億元;扣除非經常性損益後的淨利潤虧損5.03億元–7.53億元,上年同期虧損64,823.16萬元;基本每股收益虧損0.10元/股–0.15元/股;營業收入400億元–430億元。
2024年,利率市場環境持續走低,公司控股子公司國華人壽受750日移動平均國債收益率曲線下行影響,增加計提準備金,儘管國華人壽通過持續優化產品結構,提升新業務價值,降低負債成本等措施儘可能減少上述不利影響,但仍無法全部抵消增提準備金帶來的影響,從而造成虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.